PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $882,202 | +44.2% | 143,681 | +47.0% | 0.00% | – |
| Q2 2023 | $611,721 | +43.1% | 97,719 | +9.0% | 0.00% | – |
| Q1 2023 | $427,601 | -82.7% | 89,644 | -68.5% | 0.00% | -100.0% |
| Q4 2022 | $2,474,176 | +73.5% | 284,388 | +137.3% | 0.00% | 0.0% |
| Q3 2022 | $1,426,000 | -71.4% | 119,845 | -65.8% | 0.00% | -50.0% |
| Q2 2022 | $4,992,000 | +26.9% | 350,310 | +85.3% | 0.00% | +100.0% |
| Q1 2022 | $3,935,000 | +32.2% | 189,011 | +46.6% | 0.00% | 0.0% |
| Q4 2021 | $2,977,000 | +4.0% | 128,907 | +34.2% | 0.00% | 0.0% |
| Q3 2021 | $2,862,000 | +7635.1% | 96,038 | +8776.0% | 0.00% | – |
| Q2 2021 | $37,000 | -91.3% | 1,082 | -91.6% | 0.00% | – |
| Q1 2021 | $426,000 | +174.8% | 12,939 | +412.2% | 0.00% | – |
| Q4 2020 | $155,000 | +675.0% | 2,526 | +342.4% | 0.00% | – |
| Q3 2020 | $20,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |